The multiple actions of angiotensin II in atherosclerosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Yang, 1998, Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits, Arterioscler Thromb Vasc Biol, 18, 1433, 10.1161/01.ATV.18.9.1433
Song, 1998, Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys, Atherosclerosis, 138, 171, 10.1016/S0021-9150(98)00021-5
Viswanathan, 1992, Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta, J Clin Invest, 90, 1707, 10.1172/JCI116043
Wang, 1998, Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart, Hypertension, 32, 78, 10.1161/01.HYP.32.1.78
Phillips, 1993, Levels of angiotensin and molecular biology of the tissue renin angiotensin systems, Regul. Pept., 43, 1, 10.1016/0167-0115(93)90403-U
Rakugi, 1993, Vascular injury induces angiotensinogen gene expression in the media and neointima, Circulation, 87, 283, 10.1161/01.CIR.87.1.283
Iwai, 1997, Induction of renin in medial smooth muscle cells by balloon injury, Hypertension, 29, 1044, 10.1161/01.HYP.29.4.1044
Diet, 1996, Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease, Circulation, 94, 2756, 10.1161/01.CIR.94.11.2756
Schieffer, 2000, Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability, Circulation, 101, 1372, 10.1161/01.CIR.101.12.1372
Fukuhara, 2000, Angiotensin-converting enzyme expression in human carotid artery atherosclerosis, Hypertension, 35, 353, 10.1161/01.HYP.35.1.353
Ohishi, 1999, Relative localization of angiotensin-converting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions, J Hypertens, 17, 547, 10.1097/00004872-199917040-00013
Ihara, 1999, Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta, Hypertension, 33, 1399, 10.1161/01.HYP.33.6.1399
Potter, 1998, Evidence that macrophages in atherosclerotic lesions contain angiotensin II, Circulation, 98, 800, 10.1161/01.CIR.98.8.800
Griendling, 1994, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells, Circ Res, 74, 1141, 10.1161/01.RES.74.6.1141
Mugge, 1998, The role of reactive oxygen species in atherosclerosis, Z Kardiol, 87, 851
Ohara, 1993, Hypercholesterolemia increases endothelial superoxide anion production, J Clin Invest, 91, 2546, 10.1172/JCI116491
Mugge, 1994, Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits, J Cardiovasc Pharmacol, 24, 994, 10.1097/00005344-199424060-00019
Ushio-Fukai, 1996, p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells, J Biol Chem, 271, 23317, 10.1074/jbc.271.38.23317
Zhang, 1999, Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases, Cardiovasc Res, 44, 215, 10.1016/S0008-6363(99)00183-2
Yanagitani, 1999, Angiotensin II type 1 receptor-mediated peroxide production in human macrophages, Hypertension, 33, 335, 10.1161/01.HYP.33.1.335
Keidar, 1995, Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins, Atherosclerosis, 115, 201, 10.1016/0021-9150(94)05514-J
Scheidegger, 1997, Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway, J Biol Chem, 272, 21609, 10.1074/jbc.272.34.21609
Rajagopalan, 1996, Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone, J Clin Invest, 97, 1916, 10.1172/JCI118623
Warnholtz, 1999, Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin–angiotensin system, Circulation, 99, 2027, 10.1161/01.CIR.99.15.2027
Furchgott, 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373, 10.1038/288373a0
Ignarro, 1987, Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide, Proc Natl Acad Sci USA, 84, 9265, 10.1073/pnas.84.24.9265
Palmer, 1987, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor, Nature, 327, 524, 10.1038/327524a0
Griendling, 1997, Angiotensin II signaling in vascular smooth muscle. New concepts, Hypertension, 29, 366, 10.1161/01.HYP.29.1.366
Imai, 1992, Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells, Hypertension, 19, 753, 10.1161/01.HYP.19.6.753
Beckman, 1996, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly, Am J Physiol, 271, C1424, 10.1152/ajpcell.1996.271.5.C1424
Aviram, 1993, Modified forms of low density lipoprotein and atherosclerosis, Atherosclerosis, 98, 1, 10.1016/0021-9150(93)90217-I
Dhaliwal, 1999, Scavenger receptors and oxidized low density lipoproteins, Clin Chim Acta, 286, 191, 10.1016/S0009-8981(99)00101-1
Li, 2000, Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors, Arterioscler Thromb Vasc Biol, 20, 1116, 10.1161/01.ATV.20.4.1116
Hayek, 1998, Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice, J Cardiovasc Pharmacol, 31, 540, 10.1097/00005344-199804000-00011
Keidar, 1997, The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice, Biochem Biophys Res Commun, 236, 622, 10.1006/bbrc.1997.6844
Keidar, 1997, Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a proteoglycan-mediated pathway, Biochem Biophys Res Commun, 239, 63, 10.1006/bbrc.1997.7428
Hayek, 2000, Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients, Biochem Biophys Res Commun, 273, 417, 10.1006/bbrc.2000.2963
Kaplan, 2000, Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein, Atherosclerosis, 149, 5, 10.1016/S0021-9150(99)00287-7
Mehta, 1998, Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells, Biochem Biophys Res Commun, 248, 511, 10.1006/bbrc.1998.9004
Aoyama, 2000, LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells, FEBS Lett, 467, 217, 10.1016/S0014-5793(00)01154-6
Li, 1999, Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation [see comments], Circ Res, 84, 1043, 10.1161/01.RES.84.9.1043
Morawietz, 1999, Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein, Circulation, 100, 899, 10.1161/01.CIR.100.9.899
Mehta, 2000, Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease?, Drugs, 59, 159, 10.2165/00003495-200059020-00001
Ross, 1999, Atherosclerosis — an inflammatory disease [see comments], New Engl J Med, 340, 115, 10.1056/NEJM199901143400207
Kranzhofer, 1999, Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes, Biochem Biophys Res Commun, 257, 826, 10.1006/bbrc.1999.0543
Ruiz-Ortega, 2000, Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms, Circ Res, 86, 1266, 10.1161/01.RES.86.12.1266
Pueyo, 2000, Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress, Arterioscler Thromb Vasc Biol, 20, 645, 10.1161/01.ATV.20.3.645
Chen, 1998, Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells, Circ Res, 83, 952, 10.1161/01.RES.83.9.952
Liao, 1993, Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice, J Clin Invest, 91, 2572, 10.1172/JCI116495
Hernandez-Presa, 1997, Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis, Circulation, 95, 1532, 10.1161/01.CIR.95.6.1532
Liao, 1994, Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice, J Clin Invest, 94, 877, 10.1172/JCI117409
Davies, 1993, The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis, J Pathol, 171, 223, 10.1002/path.1711710311
Nakashima, 1998, Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse, Arterioscler Thromb Vasc Biol, 18, 842, 10.1161/01.ATV.18.5.842
Tummala, 1999, Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin–angiotensin system and atherosclerosis, Circulation, 100, 1223, 10.1161/01.CIR.100.11.1223
Pastore, 1999, Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo, Circulation, 100, 1646, 10.1161/01.CIR.100.15.1646
Grafe, 1997, Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin, Circ Res, 81, 804, 10.1161/01.RES.81.5.804
Sasayama, 2000, Chemokines and cardiovascular diseases [editorial; comment], Cardiovasc Res, 45, 267, 10.1016/S0008-6363(99)00381-8
Yla-Herttuala, 1991, Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions, Proc Natl Acad Sci USA, 88, 5252, 10.1073/pnas.88.12.5252
Nelken, 1991, Monocyte chemoattractant protein-1 in human atheromatous plaques, J Clin Invest, 88, 1121, 10.1172/JCI115411
Hernandez-Presa, 1998, ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis, Am J Pathol, 153, 1825, 10.1016/S0002-9440(10)65697-0
Soejima, 1999, Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction, J Am Coll Cardiol, 34, 983, 10.1016/S0735-1097(99)00318-6
Yudkin, 1999, Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?, Atherosclerosis, 148, 209, 10.1016/S0021-9150(99)00463-3
Ikeda, 1991, Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner, Am J Physiol, 260, H1713
Kishimoto, 1995, Interleukin-6 family of cytokines and gp130, Blood, 86, 1243, 10.1182/blood.V86.4.1243.bloodjournal8641243
Ikeda, 1992, Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits, Atherosclerosis, 92, 213, 10.1016/0021-9150(92)90280-T
Kranzhofer, 1999, Angiotensin induces inflammatory activation of human vascular smooth muscle cells, Arterioscler Thromb Vasc Biol, 19, 1623, 10.1161/01.ATV.19.7.1623
Han, 1999, Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors, Circ Res, 84, 695, 10.1161/01.RES.84.6.695
Rabbani, 1999, Strategies to achieve coronary arterial plaque stabilization, Cardiovasc Res, 41, 402, 10.1016/S0008-6363(98)00279-X
Takagishi, 1995, Effect of angiotensin II and thromboxane A2 on the production of matrix metalloproteinase by human aortic smooth muscle cells, Biochem Mol Biol Int, 35, 265
Kim, 2000, Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases, Pharmacol Rev, 52, 11
Viedt, 2000, Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species, Arterioscler Thromb Vasc Biol, 20, 940, 10.1161/01.ATV.20.4.940
Deguchi, 1999, Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms, Circ Res, 85, 565, 10.1161/01.RES.85.7.565
Ushio-Fukai, 1998, p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy, J Biol Chem, 273, 15022, 10.1074/jbc.273.24.15022
Hamaguchi, 1999, Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells, Hypertension, 34, 126, 10.1161/01.HYP.34.1.126
Kusuhara, 1998, p38 Kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2, Circ Res, 83, 824, 10.1161/01.RES.83.8.824
Tamura, 1998, Mechanism of angiotensin II-mediated regulation of fibronectin gene in rat vascular smooth muscle cells, J Biol Chem, 273, 26487, 10.1074/jbc.273.41.26487
Kim, 1998, Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery, Circulation, 97, 1731, 10.1161/01.CIR.97.17.1731
Berk, 1999, Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases, J Am Soc Nephrol, 10, S62
Marrero, 1995, Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor, Nature, 375, 247, 10.1038/375247a0
Marrero, 1997, Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation, J Biol Chem, 272, 24684, 10.1074/jbc.272.39.24684
Seki, 2000, Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury, Circ Res, 87, 12, 10.1161/01.RES.87.1.12
Newby, 1999, Fibrous cap formation or destruction — the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation, Cardiovasc Res, 41, 345, 10.1016/S0008-6363(98)00286-7
Geisterfer, 1988, Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells, Circ Res, 62, 749, 10.1161/01.RES.62.4.749
Berk, 1989, Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells, Hypertension, 13, 305, 10.1161/01.HYP.13.4.305
Xi, 1999, Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells, Arterioscler Thromb Vasc Biol, 19, 73, 10.1161/01.ATV.19.1.73
Zafari, 1998, Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy, Hypertension, 32, 488, 10.1161/01.HYP.32.3.488
Fingerle, 1995, Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries, Arterioscler Thromb Vasc Biol, 15, 1945, 10.1161/01.ATV.15.11.1945
Braun-Dullaeus, 1999, A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy [see comments], J Clin Invest, 104, 815, 10.1172/JCI5339
Daemen, 1991, Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall, Circ Res, 68, 450, 10.1161/01.RES.68.2.450
Su, 1998, Mitogenic effect of angiotensin II on rat carotid arteries and type II or III mesenteric microvessels but not type I mesenteric microvessels is mediated by endogenous basic fibroblast growth factor, Circ Res, 82, 321, 10.1161/01.RES.82.3.321
Griffin, 1991, Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism, Hypertension, 17, 626, 10.1161/01.HYP.17.5.626
Gibbons, 1992, Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II, J Clin Invest, 90, 456, 10.1172/JCI115881
Naftilan, 1989, Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells, J Clin Invest, 83, 1419, 10.1172/JCI114032
Delafontaine, 1993, Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells, J Biol Chem, 268, 16866, 10.1016/S0021-9258(19)85496-0
Itoh, 1993, Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II, J Clin Invest, 91, 2268, 10.1172/JCI116454
Temizer, 1992, Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells, J Biol Chem, 267, 24892, 10.1016/S0021-9258(18)35847-2
Taylor, 1999, Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin, Proc Natl Acad Sci USA, 96, 1633, 10.1073/pnas.96.4.1633
Abe, 1997, Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening, Circulation, 96, 1906, 10.1161/01.CIR.96.6.1906
Kato, 1991, Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells, J Hypertens, 9, 17, 10.1097/00004872-199109010-00003
Kim, 1994, AT1 receptor-mediated stimulation by angiotensin II of rat aortic fibronectin gene expression in vivo, Br J Pharmacol, 113, 662, 10.1111/j.1476-5381.1994.tb17042.x
Kim, 1995, Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery, Circulation, 92, 88, 10.1161/01.CIR.92.1.88
Regenass, 1994, Angiotensin-II-induced expression of laminin complex and laminin A-chain-related transcripts in vascular smooth muscle cells, J Vasc Res, 31, 163, 10.1159/000159042
Tokimitsu, 1994, Elastin synthesis is inhibited by angiotensin II but not by platelet-derived growth factor in arterial smooth muscle cells, Biochim Biophys Acta, 1207, 68, 10.1016/0167-4838(94)90052-3
Wiener, 1996, Immunohistochemical and molecular characterization of the differential response of the rat mesenteric microvasculature to angiotensin-II infusion, J Vasc Res, 33, 195, 10.1159/000159148
Ling, 1999, Matrix-dependent gene expression of egr-1 and PDGF A regulate angiotensin II-induced proliferation in human vascular smooth muscle cells, Hypertension, 34, 1141, 10.1161/01.HYP.34.5.1141
LaFleur, 1994, Cloning and characterization of alternatively spliced isoforms of rat tenascin. Platelet-derived growth factor-BB markedly stimulates expression of spliced variants of tenascin mRNA in arterial smooth muscle cells, J Biol Chem, 269, 20757, 10.1016/S0021-9258(17)32057-4
Dimmeler, 2000, Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors [In Process Citation], Regul Pept, 90, 19, 10.1016/S0167-0115(00)00105-1
MacLellan, 1997, Death by design. Programmed cell death in cardiovascular biology and disease, Circ Res, 81, 137, 10.1161/01.RES.81.2.137
Saraste, 2000, Morphologic and biochemical hallmarks of apoptosis, Cardiovasc Res, 45, 528, 10.1016/S0008-6363(99)00384-3
McCarthy, 2000, The regulation of vascular smooth muscle cell apoptosis, Cardiovasc Res, 45, 747, 10.1016/S0008-6363(99)00275-8
Saraste, 2000, Morphologic and biochemical hallmarks of apoptosis, Cardiovasc Res, 45, 528, 10.1016/S0008-6363(99)00384-3
Li, 1999, Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation, Am J Physiol, 276, H786
Dimmeler, 1997, Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide, Circ Res, 81, 970, 10.1161/01.RES.81.6.970
Pollman, 1996, Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II, Circ Res, 79, 748, 10.1161/01.RES.79.4.748
Miyashita, 1994, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo, Oncogene, 9, 1799
Li, 1999, Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: role of AT1 receptor activation, Cardiovasc Res, 41, 109, 10.1016/S0008-6363(98)00196-5
Diep, 1999, In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels, Hypertension, 34, 617, 10.1161/01.HYP.34.4.617
Tremoli, 1999, Tissue factor in atherosclerosis, Atherosclerosis, 144, 273, 10.1016/S0021-9150(99)00063-5
Vaughan, 1998, Fibrinolytic balance, the renin–angiotensin system and atherosclerotic disease, Eur Heart J, 19, G9
Edgington, 1991, The structural biology of expression and function of tissue factor, Thromb Haemost, 66, 67, 10.1055/s-0038-1646375
Wilcox, 1989, Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque, Proc Natl Acad Sci USA, 86, 2839, 10.1073/pnas.86.8.2839
Nishimura, 1997, Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells, Thromb Haemost, 77, 1189, 10.1055/s-0038-1656136
Taubman, 1993, Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation, J Clin Invest, 91, 547, 10.1172/JCI116234
Dechend, 2000, AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor [see comments], Circulation, 101, 2382, 10.1161/01.CIR.101.20.2382
Napoleone, 2000, Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes, Circ Res, 86, 139, 10.1161/01.RES.86.2.139
Soejima, 1996, Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction, Am J Cardiol, 78, 336, 10.1016/S0002-9149(96)00288-3
Schneiderman, 1992, Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries, Proc Natl Acad Sci USA, 89, 6998, 10.1073/pnas.89.15.6998
van Leeuwen, 1994, Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells, Circulation, 90, 362, 10.1161/01.CIR.90.1.362
Feener, 1995, Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells, J Clin Invest, 95, 1353, 10.1172/JCI117786
Kerins, 1995, Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV, J Clin Invest, 96, 2515, 10.1172/JCI118312
Nishimura, 1997, Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells, Thromb Haemost, 77, 1189, 10.1055/s-0038-1656136
Ridker, 1993, Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin–angiotensin system and fibrinolytic function, Circulation, 87, 1969, 10.1161/01.CIR.87.6.1969